UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mismatch repair status predicts survival after adjuvant treatment in stage II colon cancer patients

Journal of surgical oncology, 2020-02, Vol.121 (2), p.392-401

2020

Volltextzugriff (PDF)

Doctors' Failure in Observance of the COPD Management Guidelines: Case of the CZECH Republic

Value in health, 2014-11, Vol.17 (7), p.A603-A603

2014

Volltextzugriff (PDF)

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

ESMO open, 2023-02, Vol.8 (1), p.100747-100747, Article 100747

2023

Volltextzugriff (PDF)

Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in Croatia National Vaccination Program

Value in health, 2014-11, Vol.17 (7), p.A608-A609

2014

Volltextzugriff (PDF)

Modeled Outcomes and Overall Costs of the 13-Valent Pneumococcal Conjugate Vaccine in the Tunisian National Vaccination Program

Value in health, 2014-11, Vol.17 (7), p.A607-A608

2014

Volltextzugriff (PDF)

Effect of perceived and objectively-assessed frailty on outcomes in edoxaban-treated patients with atrial fibrillation: data from the ETNA-AF-Europe 4-year follow-up

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Multicriteria Decision Analysis (MCDA) In HTA – Pilot Study in the Czech Republic

Value in health, 2014-11, Vol.17 (7), p.A439-A439

2014

Volltextzugriff (PDF)

The Importance of Prognostic Factors in Premenopausal Women with Breast Cancer

Anticancer research, 2007-07, Vol.27 (4A), p.1893-1896

2007

Volltextzugriff (PDF)

Two-year outcomes of patients with atrial fibrillation and heart failure: the ETNA-AF-Europe registry

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Baseline demographic and clinical characteristics as predictors of adverse outcomes to improve management of patients with AF receiving edoxaban: a subanalysis of the ETNA-AF registry

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Cytokines as Plasma Markers of Abdominal Aortic Aneurysm

Clinical chemistry and laboratory medicine, 2000-11, Vol.38 (11), p.1161-1164

2000

Volltextzugriff (PDF)

Qualitative and Quantitative Detection of Urinary Human Complement Factor H-Related Protein (BTA stat and BTA TRAK) and Fragments of Cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as Markers for Transitional Cell Carcinoma of the Bladder

European urology, 2002-01, Vol.41 (1), p.34-39

2002

Volltextzugriff (PDF)

The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Real-world effectiveness and safety of edoxaban in patients with and without a history of ischaemic stroke: results from the ETNA-AF programme

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome

Journal of human hypertension, 2004-02, Vol.18 (2), p.107-111

2004

Volltextzugriff (PDF)

Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: influence of arterial hypertension

Physiological research, 2008, Vol.57 (1), p.13-22

2008

Volltextzugriff (PDF)

Hypothalamo-pituitary dysfunction in patients with chronic subdural hematoma

Physiological research, 2012-01, Vol.61 (2), p.161-167

2012

Volltextzugriff (PDF)

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

Lung cancer (Amsterdam, Netherlands), 2004-10, Vol.46 (1), p.87-98

2004

Volltextzugriff (PDF)

P668Aspirin for primary prevention of cardiovascular disease

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(113)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mismatch repair status predicts survival after adjuvant treatment in stage II colon cancer patients

Doctors' Failure in Observance of the COPD Management Guidelines: Case of the CZECH Republic

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in Croatia National Vaccination Program

Modeled Outcomes and Overall Costs of the 13-Valent Pneumococcal Conjugate Vaccine in the Tunisian National Vaccination Program

Effect of perceived and objectively-assessed frailty on outcomes in edoxaban-treated patients with atrial fibrillation: data from the ETNA-AF-Europe 4-year follow-up

Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry

Multicriteria Decision Analysis (MCDA) In HTA – Pilot Study in the Czech Republic

The Importance of Prognostic Factors in Premenopausal Women with Breast Cancer

Two-year outcomes of patients with atrial fibrillation and heart failure: the ETNA-AF-Europe registry

Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme

The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe

Baseline demographic and clinical characteristics as predictors of adverse outcomes to improve management of patients with AF receiving edoxaban: a subanalysis of the ETNA-AF registry

Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry

Cytokines as Plasma Markers of Abdominal Aortic Aneurysm

Qualitative and Quantitative Detection of Urinary Human Complement Factor H-Related Protein (BTA stat and BTA TRAK) and Fragments of Cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as Markers for Transitional Cell Carcinoma of the Bladder

The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure

Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe

Real-world effectiveness and safety of edoxaban in patients with and without a history of ischaemic stroke: results from the ETNA-AF programme

Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome

Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: influence of arterial hypertension

Hypothalamo-pituitary dysfunction in patients with chronic subdural hematoma

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

P668Aspirin for primary prevention of cardiovascular disease

Suchergebnisse filtern